To B or not to B: Role of B cells in pathogenesis of arthritis in HLA transgenic mice

Journal of Autoimmunity

Volumn 37, Issue 2, 2011, Pages 95-103

  Behrens, Marshall ^a   Smart, Michele ^a   Luckey, David ^a   Luthra, Harvinder ^b   Taneja, Veena ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b Mayo Clinic   (United States)

Author keywords

Antigen presentation; B cells; HLA transgenic mice; MHC polymorphism; Rheumatoid arthritis

Indexed keywords

COLLAGEN TYPE 2; EPITOPE; HLA ANTIGEN; HLA DQ8 ANTIGEN; HLA DR ANTIGEN; RHEUMATOID FACTOR;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL SURFACE; CYTOKINE RELEASE; FEMALE; HAPLOTYPE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; TRANSGENE;

ANIMALS; ANTIGEN PRESENTATION; ARTHRITIS; AUTOANTIBODIES; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; COLLAGEN TYPE II; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; MICE; MICE, TRANSGENIC; SEX FACTORS;

EID: 80052648266     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2011.05.002     Document Type: Article

References (84)

1. Lin J.P., Cash J.M., Doyle S.Z., Peden S., Kanik K., Amos C.I., et al. Familial clustering of rheumatoid arthritis with other autoimmune diseases. Hum Genet 1998, 103:475-482.
2. Taneja V., Singh R.R., Malaviya A.N., Anand C., Mehra N.K. Occurrence of autoimmune diseases and relationship of autoantibody expression with HLA phenotypes in multicase rheumatoid arthritis families. Scand J Rheumatol 1993, 22:152-157.
3. Silman A.J., MacGregor A.J., Thomson W., Holligan S., Carthy D., Farhan A., et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 1993, 32:903-907.
4. Newton J.L., Harney S.M., Wordsworth B.P., Brown M.A. A review of the MHC genetics of rheumatoid arthritis. Genes Immun 2004, 5:151-157.
5. Gregersen P.K., Silver J., Winchester R.J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987, 30:1205-1213.
6. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 1978, 298:869-871.
7. Gregersen P.K., Shen M., Song Q.L., Merryman P., Degar S., Seki T., et al. Molecular diversity of HLA-DR4 haplotypes. Proc Natl Acad Sci U S A 1986, 83:2642-2646.
8. Begovich A.B., McClure G.R., Suraj V.C., Helmuth R.C., Fildes N., Bugawan T.L., et al. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol 1992, 148:249-258.
9. Taneja V., Mehra N.K., Chandershekaran A.N., Ahuja R.K., Singh Y.N., Malaviya A.N. HLA-DR4-DQw8, but not DR4-DQw7 haplotypes occur in Indian patients with rheumatoid arthritis. Rheumatol Int 1992, 11:251-255.
10. Lanchbury J.S., Jaeger E.E., Sansom D.M., Hall M.A., Wordsworth P., Stedeford J., et al. Strong primary selection for the Dw4 subtype of DR4 accounts for the HLA-DQw7 association with Felty's syndrome. Hum Immunol 1991, 32:56-64.
11. Liu C., Ackerman H.H., Carulli J.P. A genome-wide screen of gene-gene interactions for rheumatoid arthritis susceptibility. Hum Genet 2011, 129:473-485.
12. Padyukov L., Seielstad M., Ong R.T., Ding B., Ronnelid J., Seddighzadeh M., et al. A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis. Ann Rheum Dis 2011, 70:259-265.
13. Nelson J.L., Hansen J.A. Autoimmune diseases and HLA. Crit Rev Immunol 1990, 10:307-328.
14. Mitchison N.A. Specialization, tolerance, memory, competition, latency, and strife among T cells. Annu Rev Immunol 1992, 10:1-12.
15. Moller E., Bohme J., Valugerdi M.A., Ridderstad A., Olerup O. Speculations on mechanisms of HLA associations with autoimmune diseases and the specificity of "autoreactive" T lymphocytes. Immunol Rev 1990, 118:5-19.
16. Andriopoulos N.A., Mestecky J., Miller E.J., Bradley E.L. Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis. Arthritis Rheum 1976, 19:613-617.
17. Clague R.B., Shaw M.J., Holt P.J. Incidence of serum antibodies to native type I and type II collagens in patients with inflammatory arthritis. Ann Rheum Dis 1980, 39:201-206.
18. Londei M., Savill C.M., Verhoef A., Brennan F., Leech Z.A., Duance V., et al. Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci U S A 1989, 86:636-640.
19. Tarkowski A., Klareskog L., Carlsten H., Herberts P., Koopman W.J. Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum 1989, 32:1087-1092.
20. Wooley P.H., Luthra H.S., Stuart J.M., David C.S. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 1981, 154:688-700.
21. Nabozny G.H., Baisch J.M., Cheng S., Cosgrove D., Griffiths M.M., Luthra H.S., et al. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med 1996, 183:27-37.
22. Elliott E.A., Drake J.R., Amigorena S., Elsemore J., Webster P., Mellman I., et al. The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J Exp Med 1994, 179:681-694.
23. Pieters J. MHC class II-restricted antigen processing and presentation. Adv Immunology 2000, 75:159-208.
24. Taneja V., Hansen J., Smart M., Griffiths M., Luthra H., David C.S. Expression of the H2-E molecule mediates protection to collagen-induced arthritis in HLA-DQ8 transgenic mice: role of cytokines. Int Immunol 1997, 9:1213-1219.
25. Krco C.J., Pawelski J., Harders J., McCormick D., Griffiths M., Luthra H.S., et al. Characterization of the antigenic structure of human type II collagen. J Immunol 1996, 156:2761-2768.
26. Taneja V., Taneja N., Behrens M., Griffiths M.M., Luthra H.S., David C.S. Requirement for CD28 may not be absolute for collagen-induced arthritis: study with HLA-DQ8 transgenic mice. J Immunol 2005, 174:1118-1125.
27. Taneja V., Griffiths M.M., Luthra H., David C.S. Modulation of HLA-DQ-restricted collagen-induced arthritis by HLA-DRB1 polymorphism. Int Immunol 1998, 10:1449-1457.
28. Taneja V., Behrens M., Basal E., Sparks J., Griffiths M.M., Luthra H., et al. Delineating the role of the HLA-DR4 "shared epitope" in susceptibility versus resistance to develop arthritis. J Immunol 2008, 181:2869-2877.
29. Taneja V., Behrens M., Mangalam A., Griffiths M.M., Luthra H.S., David C.S. New humanized HLA-DR4-transgenic mice that mimic the sex bias of rheumatoid arthritis. Arthritis Rheum 2007, 56:69-78.
30. Van Boxel J.A., Paget S.A. Predominantly T-cell infiltrate in rheumatoid synovial membranes. N Engl J Med 1975, 293:517-520.
31. Khazaei H.A., Lunardi C., So A.K. CD4 T cells in the rheumatoid joint are oligoclonally activated and change during the course of disease. Ann Rheum Dis 1995, 54:314-317.
32. Herzog C., Walker C., Muller W., Rieber P., Reiter C., Riethmuller G., et al. Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells. J Autoimmun 1989, 2:627-642.
33. He X., Kang A.H., Stuart J.M. Accumulation of T cells reactive to type II collagen in synovial fluid of patients with rheumatoid arthritis. J Rheumatol 2000, 27:589-593.
34. He X., Kang A.H., Stuart J.M. Anti-Human type II collagen CD19+ B cells are present in patients with rheumatoid arthritis and healthy individuals. J Rheumatol 2001, 28:2168-2175.
35. Mauri C., Chu C.Q., Woodrow D., Mori L., Londei M. Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody. J Immunol 1997, 159:5032-5041.
36. Taneja V., Taneja N., Paisansinsup T., Behrens M., Griffiths M., Luthra H., et al. CD4 and CD8 T cells in susceptibility/protection to collagen-induced arthritis in HLA-DQ8-transgenic mice: implications for rheumatoid arthritis. J Immunol 2002, 168:5867-5875.
37. Taneja V., Krco C.J., Behrens M.D., Luthra H.S., Griffiths M.M., David C.S. B cells are important as antigen presenting cells for induction of MHC-restricted arthritis in transgenic mice. Mol Immunol 2007, 44:2988-2996.
38. Taneja V., Taneja N., Behrens M., Pan S., Trejo T., Griffiths M., et al. HLA-DRB1*0402 (DW10) transgene protects collagen-induced arthritis-susceptible H2Aq and DRB1*0401 (DW4) transgenic mice from arthritis. J Immunol 2003, 171:4431-4438.
39. de Vries R.R., Huizinga T.W., Toes R.E. Redefining the HLA and RA association: to be or not to be anti-CCP positive. J Autoimmun 2005, 25:21-25.
40. Cohen S.B. Updates from B cell trials: efficacy. J Rheumatol 2006, 77:12-17.
41. Serreze D.V., Fleming S.A., Chapman H.D., Richard S.D., Leiter E.H., Tisch R.M. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 1998, 161:3912-3918.
42. Chan O.T., Madaio M.P., Shlomchik M.J. The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev 1999, 169:107-121.
43. Matsumoto I., Maccioni M., Lee D.M., Maurice M., Simmons B., Brenner M., et al. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol 2002, 3:360-365.
44. Wooley P.H., Luthra H.S., Singh S.K., Huse A.R., Stuart J.M., David C.S. Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody. Mayo Clin Proc 1984, 59:737-743.
45. Ron Y., Sprent J. T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. J Immunol 1987, 138:2848-2856.
46. Constant S., Schweitzer N., West J., Ranney P., Bottomly K. B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J Immunol 1995, 155:3734-3741.
47. Shlomchik M.J., Craft J.E., Mamula M.J. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev 2001, 1:147-153.
48. Yanaba K., Bouaziz J.D., Haas K.M., Poe J.C., Fujimoto M., Tedder T.F. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28:639-650.
49. Hitchon C.A., Alex P., Erdile L.B., Frank M.B., Dozmorov I., Tang Y., et al. A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis. J Rheumatol 2004, 31:2336-2346.
50. Schneider E., Thieblemont N., De Moraes M.L., Dy M. Basophils: new players in the cytokine network. Eur Cytokine Netw 2010, 21:142-153.
51. Behrens M., Trejo T., Luthra H., Griffiths M., David C.S., Taneja V. Mechanism by which HLA-DR4 regulates sex-bias of arthritis in humanized mice. J Autoimmun 2010, 35:1-9.
52. de Waal Malefyt R., Figdor C.G., Huijbens R., Mohan-Peterson S., Bennett B., Culpepper J., et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol 1993, 151:6370-6381.
53. Defrance T., Carayon P., Billian G., Guillemot J.C., Minty A., Caput D., et al. Interleukin 13 is a B cell stimulating factor. J Exp Med 1994, 179:135-143.
54. Minty A., Chalon P., Derocq J.M., Dumont X., Guillemot J.C., Kaghad M., et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993, 362:248-250.
55. Amadori A., Zamarchi R., De Silvestro G., Forza G., Cavatton G., Danieli G.A., et al. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med 1995, 1:1279-1283.
56. Silverman G.J., Carson D.A. Roles of B cells in rheumatoid arthritis. Arthritis Res Ther 2003, 5(Suppl. 4):S1-S6.
57. Kneitz C., Wilhelm M., Tony H.P. Improvement of refractory rheumatoid arthritis after depletion of B cells. Scand J Rheumatol 2004, 33:82-86.
58. Grimaldi C.M., Cleary J., Dagtas A.S., Moussai D., Diamond B. Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest 2002, 109:1625-1633.
59. Smolen J.S., Van Der Heijde D.M., St Clair E.W., Emery P., Bathon J.M., Keystone E., et al. Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. Arthritis Rheum 2006, 54:702-710.
60. David C.S., Frelinger J.A., Schreffler D.C. Serologic detection of lymphocyte cell-surface antigens controlled by the Ir region of the H-2 gene complex. Transplant Proc 1973, 5:1815-1816.
61. David C.S., Shreffler D.C., Frelinger J.A. New lymphocyte antigen system (Lna) controlled by the Ir region of the mouse H-2 complex. Proc Natl Acad Sci U S A 1973, 70:2509-2514.
62. Shreffler D.C., David C.S. The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organization. Adv Immunol 1975, 20:125-195.
63. Blanden R.V., Doherty P.C., Dunlop M.B., Gardner I.D., Zinkernagel R.M., David C.S. Genes required for cytotoxicity against virus-infected target cells in K and D regions of H-2 complex. Nature 1975, 254:269-270.
64. Mangalam A.K., Rajagopalan G., Taneja V., David C.S. HLA class II transgenic mice mimic human inflammatory diseases. Adv Immunol 2008, 97:65-147.
65. Abraham R.S., David C.S. Identification of HLA-class-II-restricted epitopes of autoantigens in transgenic mice. Curr Opin Immunol 2000, 12:122-129.
66. Taneja V., David C.S. Role of HLA class II genes in susceptibility/resistance to inflammatory arthritis: studies with humanized mice. Immunol Rev 2010, 233:62-78.
67. Meroni P.L., Shoenfeld Y. Systemic lupus erythematosus and the SLE galaxy. Autoimmun Rev 2010, 10:1-2.
68. Gualtierotti R., Biggioggero M., Penatti A.E., Meroni P.L. Updating on the pathogenesis of systemic lupus erythematosus. Autoimmun Rev 2010, 10:3-7.
69. Katz U., Zandman-Goddard G. Drug-induced lupus: an update. Autoimmun Rev 2010, 10:46-50.
70. Youinou P., Pers J.O. The international symposium on Sjogren's syndrome in Brest: the "top of the tops" at the "tip of the tips" Autoimmun Rev 2010, 9:589-590.
71. Fauchais A.L., Martel C., Gondran G., Lambert M., Launay D., Jauberteau M.O., et al. Immunological profile in primary Sjogren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev 2010, 9:595-599.
72. Youinou P. Haralampos M. Moutsopoulos: a lifetime in autoimmunity. J Autoimmun 2010, 35:171-175.
73. Juran B.D., Lazaridis K.N. Update on the genetics and genomics of PBC. J Autoimmun 2010, 35:181-187.
74. Tsuda M., Torgerson T.R., Selmi C., Gambineri E., Carneiro-Sampaio M., Mannurita S.C., et al. The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies. J Autoimmun 2010, 35:265-268.
75. Wiik A.S., Hoier-Madsen M., Forslid J., Charles P., Meyrowitsch J. Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells. J Autoimmun 2010, 35:276-290.
76. Youinou P., Pers J.-O., Gershwin M.E., Shoenfeld Y. Geo-epidemiology and autoimmunity. J Autoimmun 2010, 34:J163-J167.
77. Chang C., Gershwin M.E. Drugs and autoimmunity - A contemporary review and mechanistic approach. J Autoimmun 2010, 34:J266-J275.
78. Chen M., Daha M.R., Kallenberg C.G.M. The complement system in systemic autoimmune disease. J Autoimmun 2010, 34:J276-J286.
79. Borchers A.T., Naguwa S.M., Keen C.L., Gershwin M.E. The implications of autoimmunity and pregnancy. J Autoimmun 2010, 34:J287-J299.
80. Kelley J.M., Edberg J.C., Kimberly R.P. Pathways: strategies for susceptibility genes in SLE. Autoimmun Rev 2010, 9:473-476.
81. Ansari A.A., Gershwin M.E. Navigating the passage between Charybdis and Scylla: recognizing the achievements of Noel Rose. J Autoimmun 2009, 33:165-169.
82. Mackay I.R. Clustering and commonalities among autoimmune diseases. J Autoimunity 2009, 33:170-177.
83. Kong Y.C.M., Morris G.P., Brown N.K., Yan Y., Flynn J.C., David C.S. Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function. J Autoimmun 2009, 33:239-246.
84. Invernizzi P., Gershwin M.E. The genetics of human autoimmune disease. J Autoimmun 2009, 33:290-299.